4.6 Article

Beneficial Roles of Cellulose Patch-Mediated Cell Therapy in Myocardial Infarction: A Preclinical Study

Journal

CELLS
Volume 10, Issue 2, Pages -

Publisher

MDPI
DOI: 10.3390/cells10020424

Keywords

implant; bacterial cellulose patch; myocardial infarction; cell therapy; delivery

Categories

Funding

  1. Coordination for the Improvement of Higher Education Personnel (CAPES)
  2. National Council for Scientific and Technological Development (CNPq)

Ask authors/readers for more resources

Using bacterial cellulose (BC) membrane patches containing cocultured cells to limit myocardial postinfarction pathology was investigated in this study. Results showed that BC played an important role in supporting cells known to produce cardioprotective soluble factors, potentially offering effective future therapeutic outcomes for patients with ischemic heart disease.
Biological scaffolds have become an attractive approach for repairing the infarcted myocardium and have been shown to facilitate constructive remodeling in injured tissues. This study aimed to investigate the possible utilization of bacterial cellulose (BC) membrane patches containing cocultured cells to limit myocardial postinfarction pathology. Myocardial infarction (MI) was induced by ligating the left anterior descending coronary artery in 45 Wistar rats, and patches with or without cells were attached to the hearts. After one week, the animals underwent echocardiography to assess for ejection fraction and left ventricular end-diastolic and end-systolic volumes. Following patch formation, the cocultured cells retained viability of >90% over 14 days in culture. The patch was applied to the myocardial surface of the infarcted area after staying 14 days in culture. Interestingly, the BC membrane without cellular treatment showed higher preservation of cardiac dimensions; however, we did not observe improvement in the left ventricular ejection fraction of this group compared to coculture-treated membranes. Our results demonstrated an important role for BC in supporting cells known to produce cardioprotective soluble factors and may thus provide effective future therapeutic outcomes for patients suffering from ischemic heart disease.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available